E.M.E. Smit
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 9
- Acute Myeloid Leukemia Research 7
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
- Genomic variations and chromosomal abnormalities 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 7
- Genomic variations and chromosomal abnormalities 4
-
- Acute Lymphoblastic Leukemia research 6
-
- DNA Repair Mechanisms 5
- Advanced biosensing and bioanalysis techniques 4
-
- Chromosomal and Genetic Variations 4
E.M.E. Smit
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Hematology 558
- Genetics 264
- Genetics 293
- Public Health, Environmental and Occupational Health 251
- Molecular Biology 526
Countries citing papers authored by E.M.E. Smit
This map shows the geographic impact of E.M.E. Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M.E. Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M.E. Smit more than expected).
Fields of papers citing papers by E.M.E. Smit
This network shows the impact of papers produced by E.M.E. Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M.E. Smit. The network helps show where E.M.E. Smit may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E.M.E. Smit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 45 | |
| 2 | The early bactericidal activity of amikacin in pulmonary tuberculosis. | 2001 | 27 |
| 3 | 1999 | 8 | |
| 4 | 1998 | 29 | |
| 5 | 1996 | 24 | |
| 6 | 1995 | 7 | |
| 7 | 1995 | 4 | |
| 8 | 1994 | 52 | |
| 9 | 1994 | 18 | |
| 10 | 1994 | 20 | |
| 11 | 1993 | 83 | |
| 12 | 1993 | 38 | |
| 13 | 1993 | 26 | |
| 14 | 1992 | 46 | |
| 15 | 1991 | 15 | |
| 16 | 1984 | 133 | |
| 17 | 1981 | 2 | |
| 18 | 1980 | 11 | |
| 19 | Cytogenetic analysis of human renal carcinoma cell lines of common origin (NC 65). | 1979 | 27 |
| 20 | 1977 | 81 |
About E.M.E. Smit
E.M.E. Smit is a scholar working on Hematology, Genetics, Molecular Medicine, Genetics and Molecular Biology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (6 papers), DNA Repair Mechanisms (5 papers), Genomic variations and chromosomal abnormalities (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Chromosomal and Genetic Variations (4 papers). The work is most often cited by research in Hematology (558 citations), Genetics (264 citations), Genetics (293 citations), Public Health, Environmental and Occupational Health (251 citations) and Molecular Biology (526 citations). E.M.E. Smit has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include A Hagemeijer, D. Bootsma, Anne Hagemeijer, A. Hagemeijer, CR Bartram, A.J. van Agthoven, K. Hählen, J.M.N. Hoovers, Bob Löwenberg and Kirsten van Lom. Their work appears in journals such as Cytogenetic and Genome Research, Genomics, British Journal of Haematology, Genes Chromosomes and Cancer and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.